Tuesday, 17 December 2024
A world-leading expert in stroke medicine at the University of Nottingham has received a prestigious award from the British Pharmacological Society (BPS) for his work that has changed clinical practice around the management of high blood pressure in acute stroke.
Philip Bath, Stroke Association Professor of Stroke Medicine and Head of Academic Stroke in the School of Medicine at the University, Emeritus National Institute of Health Research Senior Investigator, and a consultant stroke physician at Nottingham University Hospitals NHS Trust, has received the Lilly Prize from the BPS.
The award recognises outstanding achievement and leadership in clinical pharmacology and is supported by an arm’s length grant from Eli Lilly and Company Ltd.
The award recognises outstanding achievement and leadership in clinical pharmacology and is supported by an arm’s length grant from Eli Lilly and Company Ltd.
Professor Bath has had an outstanding research career, much of it focussing on understanding the clinical utility of nitric oxide, and especially using NO donors and other agents for the management of high blood pressure in acute stroke.
He has undertaken methodological research advancing clinical trial design and analysis which is now implemented worldwide. He trained in clinical pharmacology (CPT) at St George’s Hospital Medical School and uses CPT skills throughout his research and, indirectly, in his clinical stroke work. He is one of just nine stroke physicians in the Academy of Medical Sciences.
I am delighted and most honoured to receive this award from the British Pharmacological Society. The award is based around my work on the management of high blood pressure in acute stroke which started back in the 1990s; it has been a complicated story but the pieces of the puzzle are starting to fall into place and are now changing clinical practice.
This work has been delivered by a very talented team of clinical and other researchers, without whom it would never have happened. Many of these are working right now in the Stroke Trials Unit in Nottingham. Many thanks to BPS."
Story credits
More information is available Professor Philip Bath from the School of Medicine at philip.bath@nottingham.ac.uk or
Notes to editors:
About the University of Nottingham
Ranked 32 in Europe and 16th in the UK by the QS World University Rankings: Europe 2024, the University of Nottingham is a founding member of the Russell Group of research-intensive universities. Studying at the University of Nottingham is a life-changing experience, and we pride ourselves on unlocking the potential of our students. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement.
Nottingham was crowned Sports University of the Year by The Times and Sunday Times Good University Guide 2024 – the third time it has been given the honour since 2018 – and by the Daily Mail University Guide 2024.
The university is among the best universities in the UK for the strength of our research, positioned seventh for research power in the UK according to REF 2021. The birthplace of discoveries such as MRI and ibuprofen, our innovations transform lives and tackle global problems such as sustainable food supplies, ending modern slavery, developing greener transport, and reducing reliance on fossil fuels.
The university is a major employer and industry partner - locally and globally - and our graduates are the second most targeted by the UK's top employers, according to The Graduate Market in 2022 report by High Fliers Research.
We lead the Universities for Nottingham initiative, in partnership with Nottingham Trent University, a pioneering collaboration between the city’s two world-class institutions to improve levels of prosperity, opportunity, sustainability, health and wellbeing for residents in the city and region we are proud to call home.
More news…